Insider Transactions in Q1 2025 at Uni Qure N.V. (QURE)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2025
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
28,341
-4.17%
|
$283,410
$10.29 P/Share
|
Mar 04
2025
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,438
-4.57%
|
$104,380
$10.29 P/Share
|
Mar 04
2025
|
Walid Abi Saab Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,350
-0.88%
|
$13,500
$10.29 P/Share
|
Mar 04
2025
|
Jeannette Potts Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,076
-5.58%
|
$70,760
$10.29 P/Share
|
Mar 03
2025
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
99,000
+12.71%
|
-
|
Mar 03
2025
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,000
+24.24%
|
-
|
Mar 03
2025
|
Walid Abi Saab Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,000
+19.87%
|
-
|
Mar 03
2025
|
Jeannette Potts Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+21.63%
|
-
|
Feb 27
2025
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
6,717
-1.14%
|
$73,887
$11.32 P/Share
|
Feb 27
2025
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,916
-1.84%
|
$32,076
$11.32 P/Share
|
Feb 26
2025
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,324
+2.7%
|
-
|
Feb 26
2025
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,712
+3.49%
|
-
|
Feb 25
2025
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
26,727
-4.47%
|
$267,270
$10.7 P/Share
|
Feb 25
2025
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,341
-8.6%
|
$143,410
$10.7 P/Share
|